Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis

19Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study evaluated the pharmacological activity of PTX3, administered in combination with voriconazole, in a rat model of pulmonary aspergillosis. The data indicated additive therapeutic activities of these compounds, as demonstrated by the amelioration of respiratory function changes, reduction of lung fungal burden, and increased survival. Overall, we provide clear evidence that the combination of PTX3 with a suboptimal dose of voriconazole might represent a therapeutic option under those clinical conditions where the use of voriconazole alone is not warranted for efficacy and tolerability reasons. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Lo Giudice, P., Campo, S., De Santis, R., & Salvatori, G. (2012). Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy, 56(12), 6400–6402. https://doi.org/10.1128/AAC.01000-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free